Status:
COMPLETED
Project Insight: Feasibility of a Breast Cancer Screening Decision Support Tool
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Breast Cancer Screening
Oncology
Eligibility:
FEMALE
40-49 years
Phase:
NA
Brief Summary
The purpose of this investigation is to conduct a feasibility study to evaluate the potential for implementing the developed decision support tool with Latina, Black, and non-Latina White women. The i...
Eligibility Criteria
Inclusion
- Latina, Black, or non-Latina White women
- Between the ages of 40-49 years
- Can write, read, and understand English
Exclusion
- Women with greater than an average self-reported risk of breast cancer will be ineligible for participation, as evidenced by any of the following:
- Self-reported personal history of breast cancer (invasive, ductal carcinoma in situ \[DCIS\], or lobular carcinoma in situ\[LCIS\])
- Self-reported personal history of atypical hyperplasia
- Self-reported first degree family member with history of breast cancer (e.g., mother, sister)
- Self-reported known underlying genetic mutation such as a BRCA1/BRCA2 gene
- Self-reported prior thoracic or chest wall radiation therapy
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2021
Estimated Enrollment :
1277 Patients enrolled
Trial Details
Trial ID
NCT04741503
Start Date
April 19 2021
End Date
August 30 2021
Last Update
September 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110